Patient perspectives on evidence supporting drug safety and effectiveness: “What does it mean for me?”-Reference-Cited by-同舟云学术

Patient perspectives on evidence supporting drug safety and effectiveness: “What does it mean for me?”

Published:2024-05-30 Issue:9 Volume:72 Page:2874-2877
ISSN:0002-8614
Container-title:Journal of the American Geriatrics Society
language:en
Short-container-title:J American Geriatrics Society

Author:

Rand Leah Z. G.¹²^ORCID,McGraw Sarah³,Wang Junyi¹,Woloshin Steven⁴⁵,Wang Shirley V.²⁶^ORCID,Darrow Jonathan¹²^ORCID,Kesselheim Aaron S.¹²

Affiliation:

1. Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine Brigham and Women's Hospital Boston Massachusetts USA

2. Harvard Medical School Boston Massachusetts USA

3. MNW Consulting Group Portland Oregon USA

4. The Dartmouth Institute, Geisel School of Medicine, Dartmouth Hanover New Hampshire USA

5. Lisa Schwartz Foundation for Truth in Medicine Norwich, VT USA

6. Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine Brigham and Women's Hospital Boston Massachusetts USA

Funder

National Institute on Aging

Publisher

Wiley

Reference8 articles.

1. Key recommendations from the 2021 “inclusion of older adults in clinical research” workshop

2. STaRT-RWE: structured template for planning and reporting on the implementation of real world evidence studies

3. Good Practices for Real‐World Data Studies of Treatment and/or Comparative Effectiveness: Recommendations from the Joint ISPOR‐ISPE Special Task Force on Real‐World Evidence in Health Care Decision Making

4. Emulation of Randomized Clinical Trials With Nonrandomized Database Analyses

5. Dabigatran Versus Warfarin for Atrial Fibrillation in Real-World Clinical Practice